Clinical Trials Directory

Trials / Unknown

UnknownNCT02222649

Evaluation of the High Dose Vitamin D3 Supplementation Effect and Influence of Polymorphism VDR Gene on Oxidative Stress and Inflammatory Process in Elderly

EVALUATION OF THE HIGH DOSE VITAMIN D3 SUPPLEMENTATION EFFECT AND INFLUENCE OF POLYMORPHISM VDR GENE ON OXIDATIVE STRESS AND INFLAMMATORY PROCESS IN ELDERLY

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Federal University of Paraíba · Academic / Other
Sex
Female
Age
60 Years – 90 Years
Healthy volunteers
Accepted

Summary

A vitamin D3 high dose would act as an antioxidant and anti-inflammatory improving markers of oxidative stress and inflammation in the elderly. Seniors exhibiting polymorphism in the VDR gene would become non-responsive to supplementation.

Detailed description

The high prevalence of hypovitaminosis D in the elderly can be identified as a risk factor for developing cardiovascular disease and consequent increase in oxidative stress and chronic inflammation. Polymorphisms in the gene that encodes the vitamin D receptor (VDR) can influence the cellular responses supplementation of vitamin D. The study objective is to evaluate the influence of supplementation of 200,000 in a single high dose of vitamin D3 in the inflammatory status and oxidative stress elderly and the influence of polymorphism of the VDR gene in this response. One randomized, placebo-controlled clinical trial, designed with non-institutionalized elderly in northeastern Brazil will be held. All volunteers will sign the Instrument of Consent and will undergo clinical, nutritional, anthropometric and biochemical evaluation. The purpose is to produce new knowledge helping to unravel the beneficial effects of vitamin D3.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin D3High dose of 200,000 IU of cholecalciferol orally in a single dose
DIETARY_SUPPLEMENTPlaceboCapsules of starch, no therapeutic action

Timeline

Start date
2014-07-01
Primary completion
2015-05-01
Completion
2015-09-01
First posted
2014-08-21
Last updated
2015-03-06

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02222649. Inclusion in this directory is not an endorsement.